Authors: VUORISTO MS

Citation: Ms. Vuoristo, COMPLETE RESPONSES AND SURVIVAL AFTER POLYCHEMOTHERAPY PLUS INTERFERON-ALPHA FOR PATIENTS WITH METASTATIC MELANOMA, Melanoma research, 6(4), 1996, pp. 331-336

Authors: VUORISTO MS KELLOKUMPULEHTINEN P LAINE S SOPPI E

Citation: Ms. Vuoristo et al., SERUM LEVELS OF INTERLEUKIN-2, INTERLEUKIN-6 AND INTERLEUKIN-8, SOLUBLE INTERLEUKIN-2 RECEPTOR AND INTERCELLULAR-ADHESION MOLECULE-1 DURINGTREATMENT WITH INTERLEUKIN-2 PLUS INTERFERON-ALPHA, Immunopharmacology and immunotoxicology, 18(3), 1996, pp. 337-354

Authors: VUORISTO MS KELLOKUMPULEHTINEN P

Citation: Ms. Vuoristo et P. Kellokumpulehtinen, SOLUBLE IMMUNOLOGICAL PARAMETERS IN PATIENTS TREATED WITH INTERLEUKIN-2 (IL-2) PLUS INTERFERON-ALPHA (IFN), European journal of cancer, 31A, 1995, pp. 590-590

Authors: VUORISTO MS GROHN P KELLOKUMPULEHTINEN P TURUNEN M JOENSUU H KUMPULAINEN E KORPELA M TIUSANEN K NEVANTAUS A

Citation: Ms. Vuoristo et al., INTERMITTENT INTERFERON AND POLYCHEMOTHERAPY IN METASTATIC MELANOMA, Journal of cancer research and clinical oncology, 121(3), 1995, pp. 175-180